A Study of BMS-986224 in Healthy Subjects and Heart Failure Patients With Reduced Ejection Fraction

Summary

The purpose of this study is test the safety and tolerability of BMS-986224 and its effects on the body in healthy subjects and subjects with chronic heart failure with reduced ejection fraction

Timeline

Start

2017-09-22

Primary completion

2019-04-17

Completion

2019-04-17

Outcome

Outcome not reported

Stopped (Business): “Business objectives have changed”

Drugs

Indications